Burrill & Company to open office in Taiwan
2012/02/25 Washington, Feb. 24 (CNA) Burrill & Company, a U.S. life sciences merchant bank that focuses exclusively on companies involved in biotechnology and international medical industries, said Friday it will set up an office in Taiwan as part of a global investment plan. "Taiwan is in a strategically important region that offers tremendous opportunities," said G. Steven Burrill, CEO of Burrill & Company, in a statement. By investing in Taiwan, the company can broaden its access to emerging markets in China and East Asia, the San Francisco-based company said, adding that the office will also offer Taiwanese companies a window on innovation in the West and can help them grow into players on the global stage. Marietta Wu, general manager of Burrill & Company's greater China operations, will serve as manager of the office and will be in charge of investments in Taiwanese firms. Burrill participated in a BioBusiness Asia forum held by the semi-official Industrial Technology Research Institute in 2011 during his last visit to Taiwan. With an eye on the great business potential in the China market, Burrill has suggested that Taiwan take advantage of its relations with China to enter the market. The Council for Economic Planning and Development said last year the company, with US$1.5 billion in assets under management, has agreed to a US$30 million investment in Taiwanese firms.
No comments:
Post a Comment